Perioperative Management of Warfarin Interruption
In this application-based continuing pharmacy education activity Dr. Victoria Lambert, PharmD, CACP discusses the important aspects of utilizing bridge therapy for patients on long-term anticoagulation.
Pharmacists who are interested in the management of patients on anticoagulation therapy and/or who are interested in starting pharmacy services for patients on anticoagulation therapy.
This activity is not accredited for technicians.
At the conclusion of the activity, pharmacists will be able to:
- Review recommendations for when to interrupt warfarin therapy
- Review guidelines for determining thromboembolic risk
- Review recommendations for bridging therapy implementation
- Review cases for appropriate method to manage warfarain interruption based on risk stratification.
- Apply case-specific monitoring parameters for anticoagulation bridge therapy
Victoria Lambert, Pharm.D.,CACP
William W. Backus Hospital, Norwich, CT
In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity.
Dr. Victoria Lambert, PharmD, CACP has no actual or potential conflicts of interest associated with this presentation.
Click on the registration link to register for this activity. The cost is $15.00 for this activity, $120 for all 13 activities if bundled.
This activity has been supported by an educational grant from CSL Behring
The University of Connecticut, School of Pharmacy, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1 contact hour (0.1 CEU) will be awarded to pharmacists who successfully submit the assessment with a score of 70% and complete the evaluation. (ACPE #0009-0000-15-084-H01-P) Statements of credit will be uploaded to CPE Monitor within 72 hours of the completion of the evaluation and passing the quiz.
Initial release date: May 15, 2016
Planned expiration date: May 15, 2019
The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.